Futura Announces Collaboration with Menarini Korea to Commercialise MED3000 in South Korea
Futura Medical plc (AIM: FUM) (“Futura” or the “Company”), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology and currently focused on sexual health and pain, today announces it has entered into a licensing agreement with A. Menarini Korea Limited (“Menarini Korea”), a wholly owned subsidiary of Menarini Group, for […]